Literature DB >> 7532429

Intraorbital injection of amphotericin B for palliative treatment of Aspergillus orbital abscess.

K V Cahill1, C D Hogan, S L Koletar, M Gersman.   

Abstract

We report successful palliative treatment of an Aspergillus fumigatus orbital mass in a patient with acquired immunodeficiency syndrome by direct injection of amphotericin B into the abscess cavity. This case presents intraorbital injection of amphotericin B as an alternative to surgical debridement of Aspergillus orbital infection. In patients who are unable or unwilling to undergo more aggressive treatment, this procedure appears to limit morbidity while still providing effective palliative therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532429     DOI: 10.1097/00002341-199412000-00011

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  4 in total

1.  Retrobulbar amphotericin B injections for treatment of invasive sino-orbital aspergillosis.

Authors:  Toshiko Wakabayashi; Hitoshi Oda; Naoki Kinoshita; Akiko Ogasawara; Yoshinori Fujishiro; Wakako Kawanabe
Journal:  Jpn J Ophthalmol       Date:  2007-08-03       Impact factor: 2.447

Review 2.  Invasive Aspergillus Sinusitis in Human Immunodeficiency Virus Infection: Case Report and Review of the Literature.

Authors:  John M Humphrey; Thomas J Walsh; Roy M Gulick
Journal:  Open Forum Infect Dis       Date:  2016-07-26       Impact factor: 3.835

3.  Orbital compartment syndrome following retrobulbar injection of amphotericin B for invasive fungal disease.

Authors:  Frank L Brodie; Evan Kalin-Hajdu; Debbie S Kuo; Kristin E Hirabayashi; Reza Vagefi; Robert C Kersten
Journal:  Am J Ophthalmol Case Rep       Date:  2016-02-10

4.  Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.

Authors:  Ramesh Murthy; Aadhyaa Bagchi; Yogita Gote; Sanjay Desai
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.